Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:41 pm Sale | 2025-12-31 | 13G | NEUMORA THERAPEUTICS INC NMRA | K2 HealthVentures Equity Trust LLC | 8,997,035 5.010% | -2,400,275 (-21.06%) | Filing History |
| 2026-02-17 4:40 pm Sale | 2025-12-31 | 13G | ALTO NEUROSCIENCE INC ANRO | K2 HealthVentures Equity Trust LLC | 788,995 2.400% | -828,860 (-51.23%) | Filing History |
| 2025-08-11 4:55 pm Purchase | 2025-05-09 | 13G | NEUMORA THERAPEUTICS INC NMRA | K2 HealthVentures Equity Trust LLC | 11,397,310 6.600% | 11,397,310 (New Position) | Filing History |
| 2025-05-15 3:19 pm Purchase | 2025-01-13 | 13G | ALTO NEUROSCIENCE INC ANRO | K2 HealthVentures Equity Trust LLC | 1,617,855 5.600% | 1,617,855 (New Position) | Filing History |
| 2025-02-14 4:33 pm Sale | 2024-12-31 | 13G | TSCAN THERAPEUTICS INC TCRX | K2 HealthVentures Equity Trust LLC | 3,602,700 6.900% | -1,721,444 (-32.33%) | Filing History |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | TSCAN THERAPEUTICS INC TCRX | K2 HealthVentures Equity Trust LLC | 5,324,144 9.985% | 736,110 (+16.04%) | Filing History |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | ASLAN PHARMACEUTICALS LTD SPON ASLN | K2 HealthVentures Equity Trust LLC | 61,535,383 9.990% | 58,726,924 (+2091.07%) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | K2 HealthVentures Equity Trust LLC | 2,873 0.020% | -339,240 (-99.16%) | Filing History |
| 2024-02-14 4:45 pm Purchase | 2023-12-31 | 13G | TSCAN THERAPEUTICS INC TCRX | K2 HealthVentures Equity Trust LLC | 4,588,034 9.985% | 2,488,225 (+118.50%) | Filing History |
| 2024-02-14 4:45 pm Purchase | 2023-12-31 | 13G | ELEVATION ONCOLOGY INC ELEV | K2 HealthVentures Equity Trust LLC | 1,784,169 4.000% | 217,705 (+13.90%) | Filing History |
| 2024-02-14 4:45 pm Purchase | 2023-12-31 | 13G | MOLECULAR TEMPLATES INC NE MTEM | K2 HealthVentures Equity Trust LLC | 596,145 9.985% | 179,421 (+43.06%) | Filing History |
| 2024-02-14 4:45 pm Sale | 2023-12-31 | 13G | ASLAN PHARMACEUTICALS LTD SPON ASLN | K2 HealthVentures Equity Trust LLC | 2,808,459 5.200% | -499,807 (-15.11%) | Filing History |
| 2024-02-14 4:45 pm Sale | 2023-12-31 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | K2 HealthVentures Equity Trust LLC | 342,113 7.500% | -10,182,288 (-96.75%) | Filing History |
| 2024-02-14 4:41 pm Purchase | 2022-10-25 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | K2 HealthVentures Equity Trust LLC | 10,524,401 7.800% | 10,524,401 (New Position) | Filing History |
| 2023-06-26 5:27 pm Purchase | 2023-06-16 | 13G | MOLECULAR TEMPLATES INC MTEM | K2 HealthVentures Equity Trust LLC | 416,724 9.985% | 416,724 (New Position) | Filing History |
| 2023-03-20 5:20 pm Purchase | 2023-02-24 | 13G | ASLAN PHARMACEUTICALS LTD ADS ASLN | K2 HealthVentures Equity Trust LLC | 3,308,266 6.200% | 3,308,266 (New Position) | Filing History |
| 2022-11-01 4:06 pm Purchase | 2022-04-01 | 13G | ONCORUS INC ONCR | K2 HealthVentures Equity Trust LLC | 2,593,767 9.100% | 2,593,767 (New Position) | Filing History |
| 2022-09-30 5:24 pm Purchase | 2022-07-27 | 13G | ELEVATION ONCOLOGY INC ELEV | K2 HealthVentures Equity Trust LLC | 1,566,464 6.300% | 1,566,464 (New Position) | Filing History |
| 2022-09-30 5:21 pm Purchase | 2022-09-09 | 13G | TSCAN THERAPEUTICS INC TCRX | K2 HealthVentures Equity Trust LLC | 2,099,809 9.985% | 2,099,809 (New Position) | Filing History |